"finally is there the prospect that SW1 have freed up their debt...

"finally is there the prospect that SW1 have freed up their debt capability for the purpose of making an acquisition in the sector"

My thoughts exactly. Anything earnings accretive would further accelerate the growth.

If the 1/2 year comes in well, in effect, we will get a re rating to more sensible values on the back of a "a now out of danger" perception (83% recurring revenues), a further lift from the balance sheet improving, and lastly, any earnings +ve acquisition would just add fuel to the fire.

I also note that the Pfyzer vaccine has been approved for use in Australia today, which means easier access to Aged care facilities for SW1, and the royal commission findings are due in the next month.

All good catalysts for a price rise